BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23455787)

  • 21. Biopsy-Supported Tumefactive Demyelination of the Central Nervous System in Children.
    Hanumanthe SB; Francisco C; Hart J; Graves J; Waubant E
    J Child Neurol; 2016 Dec; 31(14):1528-1533. PubMed ID: 27572815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
    Yiu EM; Laughlin S; Verhey LH; Banwell BL;
    J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis.
    Tan HM; Chan LL; Chuah KL; Goh NS; Tang KK
    Br J Radiol; 2004 Feb; 77(914):153-6. PubMed ID: 15010391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumefactive demyelinating lesion: experience with two unusual patients.
    Sinha MK; Garg RK; Bhatt ML; Chandra A
    J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques.
    Barbosa BC; Marchiori E; Leal Leidersnaider C; Brandao L; Castillo M
    Neuroradiol J; 2019 Apr; 32(2):103-107. PubMed ID: 30667319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relapsing Tumefactive Demyelination: A Case Report.
    Omerhodžić I; Džurlić A; Lisica D; Mahmutbegović N; Nikšić M; Bilalović N; Suljić E
    Acta Med Acad; 2018 Nov; 47(2):193-198. PubMed ID: 30585071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumefactive demyelinating lesion. Trying to find unity in diversity. Comparison of two cases.
    Adamek D; Radwanska E; Rog T; Grzywna E; Herman-Sucharska I
    Clin Neurol Neurosurg; 2014 Jan; 116():90-2. PubMed ID: 24269051
    [No Abstract]   [Full Text] [Related]  

  • 28. MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis.
    Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
    AJNR Am J Neuroradiol; 2018 Sep; 39(9):1643-1649. PubMed ID: 30115676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumefactive demyelinating lesions of 15 patients: Clinico-radiological features, management and review of the literature.
    Sánchez P; Meca-Lallana V; Barbosa A; Manzanares R; Palmí I; Vivancos J
    J Neurol Sci; 2017 Oct; 381():32-38. PubMed ID: 28991707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma.
    Giussani C; Poliakov A; Ferri RT; Plawner LL; Browd SR; Shaw DW; Filardi TZ; Hoeppner C; Geyer JR; Olson JM; Douglas JG; Villavicencio EH; Ellenbogen RG; Ojemann JG
    Neuroimage; 2010 Aug; 52(1):217-23. PubMed ID: 20363335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumefactive Demyelinating Lesions and Pregnancy.
    Plantone D; Piantadosi C; Ruggieri S; Anelli V; Koudriavtseva T
    Neurol India; 2019; 67(6):1519-1521. PubMed ID: 31857550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric tumefactive demyelination: case series and review of the literature.
    McAdam LC; Blaser SI; Banwell BL
    Pediatr Neurol; 2002 Jan; 26(1):18-25. PubMed ID: 11814730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumefactive demyelination of the spinal cord.
    Yaghi S; Gokdin M; Sethi H
    Acta Neurol Belg; 2010 Jun; 110(2):206-8. PubMed ID: 20873455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumefactive demyelinating lesions versus CNS neoplasms, a comparative study.
    Chew SH; Achmad Sankala HB; Chew E; Md Arif MHB; Mohd Zain NR; Hashim H; Koya Kutty SB; Chee YC; Mohd Saleh NB; Ong BH; Viswanathan S
    Mult Scler Relat Disord; 2023 Nov; 79():104992. PubMed ID: 37717306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraneoplastic tumefactive demyelination with underlying combined germ cell cancer.
    Broadfoot JR; Archer HA; Coulthard E; Appelman AP; Sutak J; Braybrooke JP; Love S
    Pract Neurol; 2015 Dec; 15(6):451-5. PubMed ID: 26088612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology.
    Brück W; Bitsch A; Kolenda H; Brück Y; Stiefel M; Lassmann H
    Ann Neurol; 1997 Nov; 42(5):783-93. PubMed ID: 9392578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute demyelination: diagnostic difficulties and the need for brain biopsy.
    Maarouf M; Kuchta J; Miletic H; Ebel H; Hesselmann V; Hilker R; Sturm V
    Acta Neurochir (Wien); 2003 Nov; 145(11):961-9; discussion 969. PubMed ID: 14628201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumefactive demyelinating lesions (TDLs): A case series of clinicoradiological features.
    Jain RS; Khan I; Kandelwal K; Desai T
    Clin Neurol Neurosurg; 2017 Nov; 162():91-94. PubMed ID: 28987645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis of pediatric multiple sclerosis initially presenting with tumefactive demyelinating lesion using ¹H-magnetic resonance spectroscopy].
    Kageyama T; Gotoh Y; Sano F; Katoh T; Nambu M; Okada T; Suenaga T
    Rinsho Shinkeigaku; 2011 Sep; 51(9):688-93. PubMed ID: 21946426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimaging in postinfectious demyelination and nutritional disorders of the central nervous system.
    Lim CC
    Neuroimaging Clin N Am; 2011 Nov; 21(4):843-58, viii. PubMed ID: 22032502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.